GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer
SEOUL, South Korea, March 20, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in patients with metastatic castration-resistant...
MDJM LTD and H5 Advance Creative Development of International Animated Short Film
Intensive Script Workshops Highlight Artistic Depth and Cross-Cultural Creative Collaboration LONDON, March 16, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) ("MDJM" or the "Company") announced that the development of its animated short film project...
BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
XI'AN, China, Feb. 19, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("Bon" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, today announced the successful...
Inheritance + Innovation + Development: The "Co-development" Path of Hakka Medicine and Traditional Chinese Medicine
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- From November 23 to 25, the Seventh World Hakka Entrepreneurs Convention was held in Meizhou, Guangdong. The conference, with the theme of "Gather Global Hakka Entrepreneurs • Facilitate High-Quality...
Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development
Collaboration Aims to Expand Globally Connected Scientific Dialogue and Accelerate Innovation in Human Health and Sustainability SINGAPORE, May 7, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School...
Leading Scholars Gather at PKU Shenzhen Forum to Discuss AI and Economic Development
SHENZHEN, China, April 3, 2025 /PRNewswire/ -- The 2025 PKU Shenzhen Forum, organized by Peking University HSBC Business School (PHBS), was held March 30 at the Wuzhou Guest House in Futian District. Under the theme "Building Consensus on Reform,...
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
Clinical Trial Approval of merigolix (TU2670, HS-10518) for the inhibition of premature LH (luteinizing hormone) surges in women undergoing COS (controlled ovarian stimulation) in China SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- TiumBio...